Cancer and Metastasis Reviews

, Volume 17, Issue 2, pp 241–248 | Cite as

The pivotal role of VEGF in tumor angiogenesis: Molecular facts and therapeutic opportunities

  • Gerhard Siemeister
  • Georg Martiny-Baron
  • Dieter Marmé


Public Health Cancer Research Pivotal Role Tumor Angiogenesis Molecular Fact 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Folkman J: Angiogenesis in cancer. vascular. rheumatoid. and other discase. Nat Med 1: 27-31, 1995CrossRefPubMedGoogle Scholar
  2. 2.
    Marmé D: Tumor angiogenesis: The pivotal role of vascular endothelial growth factor (VEGF). World J Urol 14: 166-174, 1996CrossRefPubMedGoogle Scholar
  3. 3.
    Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25, 1997CrossRefPubMedGoogle Scholar
  4. 4.
    Finkenzeller G, Marmé D, Weich HA, Hug H: Platelet de rived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Res 52: 4821-4823, 1992PubMedGoogle Scholar
  5. 5.
    Brogi F, Wu T, Namiki A, Isner JM: Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth musele cells, whereas hypoxia upregulates VEGF expression only. Circulation 90: 649-652, 1994PubMedGoogle Scholar
  6. 6.
    Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, Dvorak HF: Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180: 1141-1146, 1994CrossRefPubMedGoogle Scholar
  7. 7.
    Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, Alitalo K: Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 269: 6271-6274, 1994PubMedGoogle Scholar
  8. 8.
    Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S: Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270: 12607-12613, 1995CrossRefPubMedGoogle Scholar
  9. 9.
    Li J, Perrella MA, Tsai JC, Yet SF, Hsich CM, Yoshizumi M, Patterson C, Endege WO, Zhou F, Lee ME: Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in ral aortic smooth muscle cells. J Biol Chem 270: 308-312, 1995CrossRefPubMedGoogle Scholar
  10. 10.
    Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ: Interlcukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271: 736-741, 1996PubMedGoogle Scholar
  11. 11.
    Warren RS, Yuan H, Matli MR, Ferrara N, Donner DB: Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J Biol Chem 271: 29483-29488, 1996CrossRefPubMedGoogle Scholar
  12. 12.
    Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954, 1991PubMedGoogle Scholar
  13. 13.
    Gruget S, Finkenzeller G, Weindel K, Barleon B, Marme D: Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J Biol Chem 270: 25915-25919, 1995CrossRefPubMedGoogle Scholar
  14. 14.
    Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, Kerbel RS: Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 55: 4575-4580, 1995PubMedGoogle Scholar
  15. 15.
    Mukhopadhyay D, Tsiokas L, Sukhatme VP: Wild-type p53 and v-Sre exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 55: 6161-6165, 1995PubMedGoogle Scholar
  16. 16.
    Kieser A, Weich HA, Brandner G, Marmé D, Kölch W: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9: 963-969, 1994PubMedGoogle Scholar
  17. 17.
    Siemeister G, Weindel K, Mohrs K, Barlcon B, Martiny-Baron G, Marmé D: Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Landau tumor suppressor protein. Cancer Res 56: 2299-2301, 1996PubMedGoogle Scholar
  18. 18.
    Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992CrossRefPubMedGoogle Scholar
  19. 19.
    Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992CrossRefPubMedGoogle Scholar
  20. 20.
    Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, Kohno K, Kuwano M: Induction of vascular endothelial growth factor by tumor neerosis factor α in human glioma cells: possible roles of Sp-1. J Biol Chem 271: 28220-28228, 1996CrossRefPubMedGoogle Scholar
  21. 21.
    Gille J, Swerlick RA, Caughman SW: Transforming growth factor-α-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBO J 16: 750-759, 1997CrossRefPubMedGoogle Scholar
  22. 22.
    Finkenzeller G, Sparacio A, Technau A, Marmé D, Siemeister G: Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 15: 669-676, 1997CrossRefPubMedGoogle Scholar
  23. 23.
    Mukhopadhyay D, Knebelmann B, Cohen HT, Ananth S, Sukhatme VP: The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol Cell Biol 17: 5629-5639, 1997PubMedGoogle Scholar
  24. 24.
    Duan DR, Pause A, Burgess WH, Aso T, Chen DYT, Garrett KP, Conaway RC, Conaway JW, Linchan WM, Klausner RD: Inhibition of transcription elongation by the VHL tumor suppresor protein. Science 269: 1402-1406, 1995PubMedGoogle Scholar
  25. 25.
    Aso T, Lane WS, Conaway JW, Conaway RC: Elongin (SIH): A multisubunit regulator of clongation by RNA polymerase H. Science 269: 1439-1443, 1995PubMedGoogle Scholar
  26. 26.
    Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WG Jr: Binding of the von Hippel-Lindau tumor suppressor protein to clogin B and C. Science 269: 1444-1446, 1995PubMedGoogle Scholar
  27. 27.
    Iliopoulos O, Levy AP, Jiang C, Kaclin WG Jr, Goldberg MA: Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 93: 10595-10599, 1996CrossRefPubMedGoogle Scholar
  28. 28.
    Ikeda E, Achen MG, Breier G, Risau W: Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 270: 19761-19766, 1995CrossRefPubMedGoogle Scholar
  29. 29.
    Damert A, Machein M, Breier G, Fujita MO, Hanahan D, Risau W, Plate KH: Up-regulation of vascular endothelial growth tactor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 57: 3860-3864, 1997PubMedGoogle Scholar
  30. 30.
    Levy AP, Levy NS, Goldberg MA: Post-transcriptonal regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 271: 2746-2753, 1996CrossRefPubMedGoogle Scholar
  31. 31.
    Levy AP, Levy NS, Goldberg MA: Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J Biol Chem 271: 25492-25497, 1996PubMedGoogle Scholar
  32. 32.
    Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613, 1996PubMedGoogle Scholar
  33. 33.
    Damert A, Ikeda E, Risau W: Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular endothelial growth factor expression in C6 glioma cells. Biochem J 327: 419-423, 1997PubMedGoogle Scholar
  34. 34.
    Mazure NM, Chen EY, Yeh P, Laderoute KR, Giaccia AJ: Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res 56: 3436-3440, 1996PubMedGoogle Scholar
  35. 35.
    Mazure NM, Chen EY, Laderoute KR, Giaccia AJ: Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible element. Blood 90: 3322-3331, 1997PubMedGoogle Scholar
  36. 36.
    Arbiser JL, Moses MA, Fernandez CA, Ghiso N, Cao Y, Klauber N, Frank D, Brownlee M, Flynn E, Parangi S, Byers HR, Folkman J: Oncogenic H ras stimulates tumor angiogenesis by two distinet pathways. Proc Natl Acad Sci USA 94: 861-866, 1997CrossRefPubMedGoogle Scholar
  37. 37.
    Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS, Sukhatme VP: Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375: 577-581, 1995CrossRefPubMedGoogle Scholar
  38. 38.
    Gleadle JM, Ratcliffe PJ: Induction of hypoxia-inducible factor-1, crythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for src kinase. Blood 89: 503-509, 1997PubMedGoogle Scholar
  39. 39.
    Kevil CG, De Benedetti A, Payne DK, Coe LL, Laroux FS, Alexander JS: Translational regulation of vascular permeability factor by cukaryotic initiation factor 4E: implications for tumor angiogenesis. Int J Cancer 65: 785-790, 1996CrossRefPubMedGoogle Scholar
  40. 40.
    Kerekatte V, Smilcy K, Hu B, Smith A, Gelder F, De Benedetti A: The proto-oncogene/translation factor cIF4E: a survey of its expression in breast carcinomas. Int J Cancer 64: 27-31, 1995PubMedGoogle Scholar
  41. 41.
    Miyagi Y, Sugiyama A, Asai A, Okazaki T, Kuchino Y, Kerr SJ: Elevated levels of cukaryotic translation initiation factor eIF-4E mRNA in a broad spectrum of transformed cell lines. Cancer L 91: 247-252, 1995CrossRefGoogle Scholar
  42. 42.
    Olander JV, Connolly DT, DeLarco JE: Specific binding of vascular permeability factor to endothelial cells. Biochem Biophys Res Commun 175: 68-76, 1991PubMedGoogle Scholar
  43. 43.
    Quinn TP, Peters KG, De Vries C, Ferrara N: Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 90: 7533-7537, 1993PubMedGoogle Scholar
  44. 44.
    Peters KG, De Vries C, Williams LT: Vascular endothelial growth factor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 90: 8915-8919, 1993PubMedGoogle Scholar
  45. 45.
    Millauer B, Wizigmann-Voos S, Schnürch H, Martinez R, Miller NPH, Risau W, Ullrich A: High affinity VEGT binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72: 835-846, 1993CrossRefPubMedGoogle Scholar
  46. 46.
    Klagsbrun M, D'Amore PA: Regulators of angiogenesis. Ann Rev Physiol 53: 217-239, 1991CrossRefGoogle Scholar
  47. 47.
    Frater-Schroder M, Risau W, Hallmann R, Gautsch P: Tumor necrosis factor type α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 84: 5277-5281, 1987PubMedGoogle Scholar
  48. 48.
    Leibovich S, Polverini P, Shepard H, Wisoman D, Shively V, Nuscir N: Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α. Nature 329: 630-632Google Scholar
  49. 49.
    Patterson C, Perrella MA, Endege WO, Yoshizumi M, Lee M-E, Haber E: Downregulation of vascular endothelial growth factor by tumor necrosis factor-α in cultured human vascular endothelial cells. J Clin Invest 98: 490-496, 1996PubMedGoogle Scholar
  50. 50.
    Mandnota SJ, Menoud P-A, Pepper MS: Transforming growth factor β1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells. J Biol Chem 271: 11500-11505, 1996CrossRefPubMedGoogle Scholar
  51. 51.
    Kremer C, Breier G, Risau W, Plate KH: Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. Cancer Res 57: 3852-3859, 1997PubMedGoogle Scholar
  52. 52.
    Barleon B, Siemeister G, Martiny-Baron G, Weindel K, Herzog C, Marmé D: Vascular endothelial growth factor up-regulates its receptor fms-like tytosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 57: 5421-5425, 1997PubMedGoogle Scholar
  53. 53.
    Tuder RM, Flook BE, Voelkel NF: Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. J Clin Invest 95: 1798-1807, 1995PubMedGoogle Scholar
  54. 54.
    Detmar M, Brown LF, Berse B, Jackman RW, Elicker BM, Dvorak HF, Claffey KP: Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptor in human skin. J Invest Dermatol 108: 263-268, 1997CrossRefPubMedGoogle Scholar
  55. 55.
    Thieme H, Aiello LP, Takagi H, Ferrara N, King GL: Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes 44: 98-103, 1995PubMedGoogle Scholar
  56. 56.
    Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM: Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 97: 469-476, 1996PubMedGoogle Scholar
  57. 57.
    Morishita K, Johnson DE, Williams LT: A novel promoter for vascular endothelial growth factor (flt-1) that confers endothelial specific gene expression. J Biol Chem 270: 27948-27953, 1995CrossRefPubMedGoogle Scholar
  58. 58.
    Patterson C, Perrella MA, Hsich C-M, Yoshizumi M, Lee M-E, Haber E: Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J Biol Chem 270: 23111-23118, 1995CrossRefPubMedGoogle Scholar
  59. 59.
    Rönicke V, Risau W, Breier G: Characterization of the endothelium-specific murine vascular endothelial growth factor receptor-2 (Flk-1) promoter. Circ Res 79: 277-285, 1996PubMedGoogle Scholar
  60. 60.
    Gerber H-P, Condorclli B, Park J, Ferrara N: Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. J Biol Chem 272: 23659-23667, 1997CrossRefPubMedGoogle Scholar
  61. 61.
    Millauer B, Shawver KL, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367: 576-579, 1994PubMedGoogle Scholar
  62. 62.
    Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Fenara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844, 1993PubMedGoogle Scholar
  63. 63.
    Borgström P, Hillan KJ, Sriramarao P, Ferrara N: Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibodies. Novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res 56: 4032-4039, 1996PubMedGoogle Scholar
  64. 64.
    Warren RA, Yuan H, Matli MR, Gillett NA, Ferrara N: Regulation by vascular endothelial growth factor of human colon cancer tumorigeneses in a mouse model of experimental liver metastasis. J Clin Invest 95: 1789-1797, 1995PubMedGoogle Scholar
  65. 65.
    Saleh M, Stacker SA, Wilks AF: Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56: 393-401, 1996PubMedGoogle Scholar
  66. 66.
    Petit AMV, Rak J, Hung M-C, Rockwell P, Goldstein N, Fendly B, Kerbel RS: Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors. Am J Pathol 151: 1523-1530, 1997PubMedGoogle Scholar
  67. 67.
    Skobe M, Rockwell P, Goldstein N, Vosseler S, Fusenig NE: Halting angiogenesis suppresses carcinoma cell invasion. Nature Med 3: 1222-1227, 1997CrossRefPubMedGoogle Scholar
  68. 68.
    Relf M, LeJeune S, Scott PAE, Fox S, Smith K, Leek R, Moghaddam A, Whitehouse R, Bicknell R, Harris AL: Expression of the angiogenic factors vascular endothelial growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57: 963-969, 1997PubMedGoogle Scholar
  69. 69.
    Ramakrishnan S, Olson TA, Bautch VL, Mohanraj D: Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo. Cancer Res 56: 1324-1330, 1996PubMedGoogle Scholar
  70. 70.
    Strawn LM, McMahon G, App H, Schreck R, Kuchler WR, Longhi MP, Hui TH, Tang C, Levitzki A, Gazit A, Chen I, Keri G, Orfi L, Risau W, Flamme I, Ullrich A, Hirth KP, Shawver LK: Flk-1 as a target for tumor growth inhibition. Cancer Res 56: 3540-3545, 1996PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • Gerhard Siemeister
    • 1
  • Georg Martiny-Baron
    • 1
  • Dieter Marmé
    • 1
  1. 1.Tumor Biology CenterInstitute of Molecular MedicineFreiburgGermany

Personalised recommendations